
CAS 9003-99-0PubChem CID 9865515
Mocetinostat
Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others. — DrugBank
- IUPAC 名称
- N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
- 分子式
- C23H20N6O
- 分子量
- 396.4 g/mol
- 精确质量
- 396.16985928 Da
- XLogP3
- 2.8
- 拓扑极性表面积
- 106.0 Ų
- 氢键供体
- 3
- 氢键受体
- 6
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
MGCD0103N-(2-AMINOPHENYL)-4-([[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO]METHYL)BENZAMIDEA6GWB8T96JMG0103MG-0103N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamideN-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamideN-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide
另有 16 个已报告名称
n-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamideBenzamide, N-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-MG4230MG4915MG5206MG-4230MG-4915MG-5026mocetinostatumBenzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-RefChem:926017PeroxidaseMGCD-0103MGCD 0103Mocetinostat (MGCD0103)MG 0103
外部数据库标识符
- ChEBI:CHEBI:94525
- ChEMBL:CHEMBL272980
- EPA DTXSID:DTXSID80222945
- PubMed:33770205
- PubMed:27255383
- PubMed:26775640
- PubMed:26378038
- PubMed:24200994
- PubMed:22706966
- PubMed:22382879
- PubMed:22282194
- PubMed:22123590
- PubMed:22033282
- PubMed:21668391
- PubMed:21650221
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。